Cascadian Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
04 Apr 2017	Form 3: Azelby Robert, Director Holds 0 shares of No securities were benefically held
20 Mar 2017	Form 3: Walker Luke Nathaniel, SVP, Clinical Development Holds 3,990 shares of Common Stock
01 Feb 2017	Form 3: Makower Joshua, 10% owner Holds 9,064,574 shares of Common Stock
01 Feb 2017	Form 3: Mott David M, 10% owner Holds 9,064,574 shares of Common Stock
01 Feb 2017	Form 3: Sakoda Jon, 10% owner Holds 9,064,574 shares of Common Stock
01 Feb 2017	Form 3: Viswanathan Ravi, 10% owner Holds 9,064,574 shares of Common Stock
01 Feb 2017	Form 3: Sonsini Peter W., 10% owner Holds 9,064,574 shares of Common Stock
01 Feb 2017	Form 3: Sandell Scott D, 10% owner Holds 9,064,574 shares of Common Stock
01 Feb 2017	Form 3: Florence Anthony A. Jr., 10% owner Holds 9,064,574 shares of Common Stock
01 Feb 2017	Form 3: Baskett Forest, 10% owner Holds 9,064,574 shares of Common Stock
01 Feb 2017	Form 3: Barris Peter J, 10% owner Holds 9,064,574 shares of Common Stock
01 Feb 2017	Form 3: Growth Equity Opportunities IV, Llc, 10% owner and 3 others Holds 9,064,574 shares of Common Stock
06 Apr 2016	Form 3: Myers Scott Dunseth, Director Holds 0 shares of No securities beneficially held
21 Jan 2016	Form 3: Fyfe Gwen A., Director Holds 10,000 shares of Common Stock
22 Dec 2015	Form 3: Bvf Partners L P/IL, 10% owner and 6 others Holds 4,748,420 shares of Common Stock, no par value per share
03 Mar 2015	Form 3: James Steven P, Director Holds 0 shares of No securities are beneficially owned
17 Dec 2014	Form 3: Bvf Partners L P/IL, 10% owner and 4 others Holds 6,118,870 shares of Common Stock, $0.0001 par value
12 Aug 2014	Form 3: Venkatesan Jay, EVP and General Manager Holds 50,000 shares of Common Stock
06 Sep 2013	Form 3: Love Ted W, Director Holds 0 shares of Common Stock
07 Jun 2013	Form 3: Bvf Partners L P/IL, 10% owner and 5 others Holds 4,235,529 shares of Common Stock, $0.0001 par value

Comments